ABL vs FHI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 07, 2026

ABL

42.0
AI Score
VS
ABL Wins

FHI

31.7
AI Score

Investment Advisor Scores

ABL

42score
Recommendation
HOLD

FHI

32score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric ABL FHI Winner
Forward P/E 10.5708 10.9529 ABL
PEG Ratio 0 1.543 Tie
Revenue Growth 123.7% 8.1% ABL
Earnings Growth 1700.2% 11.9% ABL
Tradestie Score 42.0/100 31.7/100 ABL
Profit Margin 5.6% 21.3% FHI
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

ABL 1M: +36.0% · 3M: +44.3% FHI 1M: +14.4% · 3M: +1.3%

Current Technical Phase

ABL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (13.4% over 20 days), RSI 68

RSI (14): 67.8 · Price: $8.47

FHI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 68

RSI (14): 68.2 · Price: $63.99

Fundamentals Snapshot

Metric ABL FHI
Market Cap — —
Forward P/E 8.6 10.7
Trailing P/E 170.0 11.9
Revenue (TTM) — —
Revenue Growth 1.2% 0.1%
Gross Margin 0.9% 0.7%
Operating Margin 0.4% 0.3%
EPS 0.05 5.39
Dividend Yield 0.00% 0.02%

Frequently Asked Questions

Based on our detailed analysis, ABL is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.